Cambridge Investment Research Advisors, Inc. Cerus Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Cerus Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 32,810 shares of CERS stock, worth $64,635. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,810
Previous 17,110
91.76%
Holding current value
$64,635
Previous $32,000
81.25%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CERS
# of Institutions
149Shares Held
147MCall Options Held
191KPut Options Held
43.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.9MShares$39.2 Million0.32% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$38.4 Million0.46% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$27.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$20.7 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.58MShares$16.9 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $349M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...